Tsimberidou, Apostolia M <br/><br/>
Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual disease.  [electronic resource] 

 -  Leukemia & lymphoma  Oct 2003 
 - 1719-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/1042819031000116706  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--immunology<br/>Antineoplastic Agents--adverse effects<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoconjugates--immunology<br/>Infusions, Intravenous<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual--drug therapy<br/>Prognosis<br/>Remission Induction<br/>Ricin--immunology<br/>Survival Rate<br/>Time Factors